Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1320 of 5804
-
Hope for rare obesity: setmelanotide tested for long-term safety
Disease control CompletedThis is an open-label extension study designed to evaluate the long-term safety and tolerability of continued setmelanotide treatment in male and female patients ≥2 years of age who have completed or transitioned from a previous study with setmelanotide for rare genetic, syndromi…
Phase: PHASE3 • Sponsor: Rhythm Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New hope for rare genetic disorder: drug ION440 enters human trials
Disease control Recruiting nowThe primary purpose of this study is to evaluate the safety and tolerability of ION440.
Phase: PHASE1, PHASE2 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Dissolvable scaffold for leg arteries under Real-World watch
Disease control OngoingThe Esprit BTK PAS is a prospective, single-arm, multi-center observational study to assess the continued safety and effectiveness of the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System under commercial use, in patients with diseased infrapopliteal lesions causing CLTI …
Phase: NA • Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
3D printed aligners could transform cleft lip care for newborns
Disease control Recruiting nowstudy will provide nasoalveolar molding (NAM) treatment, special care for infants born with cleft lip and palate. This novel appliance will help to provide the care in accurate and easy form by help of both digital work flow and new material which provide a unique properties.
Phase: NA • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Classroom lights and phone apps aim to stop Kids' Short-Sightedness
Prevention Recruiting nowThe goal of this clinical trial is to evaluate whether the optimization of daily exposure to light in primary school children can lead to better myopia prevention and control. The trial also aims to better understand the impact of light exposure on sleep and cognitive performance…
Phase: NA • Sponsor: National University of Singapore • Aim: Prevention
Last updated Jun 27, 2026 07:51 UTC
-
Could amniotic fluid injections ease knee arthritis pain?
Disease control Recruiting nowThere have been few clinical trials on ASA for the treatment of knee osteoarthritis, and there is currently no literature reporting the optimal treatment dosage. Non-surgical treatment options include braces, weight loss, lifestyle changes, oral pain relievers, and intra-articula…
Phase: PHASE3 • Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
New drug aims to calm overactive immune system in rare disorders
Disease control OngoingThis study is an exploratory, non-randomized, open-label, within-patient dose escalation study. The primary objective is to assess safety and tolerability of leniolisib. Secondary objectives include assessments of PK/PD, and to explore clinical efficacy measures with administrati…
Phase: PHASE2 • Sponsor: Pharming Technologies B.V. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New embryo transfer device aims to boost IVF success
Disease control Recruiting nowInfertility is defined as the inability to conceive within a year of unprotected intercourse. Infertility affects one in six couples and represents a public health problem causing feelings of helplessness, depression, and anxiety in both women and men worldwide. Despite the desir…
Phase: NA • Sponsor: Premium Fertility • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Magnetic pulses to the brain may help stroke survivors move again
Symptom relief CompletedThis is a multicenter, sham-controlled, double-blind, randomized clinical trial to evaluate the efficacy and safety of lesion network mapping navigated cTBS in improving motor function in patients with acute ischemic stroke within 14 days of symptom onset.
Phase: PHASE2 • Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Could a brief therapy tame OCD? new pakistan trial aims to find out
Symptom relief Recruiting nowThe purpose aims to assess the efficacy of Brief Culturally Adapted Cognitive Behaviour Therapy (Ca-CBT) for the treatment of Obsessive Compulsive Disorder (OCD).
Phase: NA • Sponsor: Pakistan Association of Cognitive Therapists • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
New combo shot may cut migraine days in half
Symptom relief CompletedThis is a multicenter, prospective, observational, propensity score matching, cohort, and assessor-blinded study designed to compare the effectiveness and safety of lidocaine combined Platelet-rich plasma (PRP) acting on SGB versus lidocaine alone acting on SGB in patients with C…
Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Needle power: acupuncture may ease Chemo's toll on breast cancer patients
Symptom relief Recruiting nowThis randomized controlled clinical trial aims to evaluate the effect of electroacupuncture combined with self-acupressure on the quality of life of early-stage breast cancer patients receiving chemotherapy.
Phase: NA • Sponsor: Jiuda Zhao • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Could a simple nerve block ease menstrual migraines?
Symptom relief Completed: The primary objective of this prospective, randomized, double-blind, placebo-controlled clinical trial is to evaluate whether repetitive bilateral greater occipital nerve (GON) blockade administered with a local anesthetic (0.5% bupivacaine) significantly reduces headache sever…
Phase: NA • Sponsor: Saglik Bilimleri Universitesi • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Cannabis oil shows promise for fibromyalgia sufferers
Symptom relief OngoingRecently, medical cannabis has been shown to be effective in chronic pain conditions such as osteoarthritis, neuropathic pain, and other chronic non-cancer pain. A study showed that fibromyalgia patients who use cannabis report significant improvement in pain symptoms and qualit…
Sponsor: Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Lab-Grown tumor avatars could pick the right cancer drug for each patient
Knowledge-focused Recruiting nowPrecision oncology aims to improve clinical outcome of patients by offering personalized treatment through identifying druggable genomic aberrations within their tumors. This is particularly valid when it comes to offering alternative treatment options for patients with advanced …
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
New Triple-Action antibody takes on Hard-to-Treat cancers
Disease control Recruiting nowThis is a first-in-human (FIH), Phase 1a/1b, open-label, multicenter, dose escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary antitumor activity of BG-T187 alone and in combination with other therapeu…
Phase: PHASE1 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Faith-Based program aims to prevent blindness in black americans at high risk for glaucoma
Prevention Recruiting nowThe purpose of this research is to evaluate if intervention and education can change the behavior of someone's willingness to see an eye care provider to prevent blindness and glaucoma. The researchers are investigating if adding additional resources improves participant access t…
Phase: NA • Sponsor: University of Michigan • Aim: Prevention
Last updated Jun 27, 2026 09:10 UTC
-
New pill could ease diabetic nerve pain in landmark trial
Symptom relief Recruiting nowThe purpose of this study is to evaluate the efficacy, safety, and tolerability of VX-993 in participants with pain associated with Diabetic Peripheral Neuropathy (DPN)
Phase: PHASE2 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Hair loss pill for women? new trial tests oral minoxidil
Disease control Recruiting nowThe goal of this clinical trial is to learn about oral minoxidil 1mg in the treatment of women with androgenetic alopecia, a type of hormone-imbalanced hair loss. The main questions to answer are to know about that minoxidil 1mg is as effective as minoxidil 2% topical solution (…
Phase: PHASE3 • Sponsor: Industrial Farmacéutica Cantabria, S.A. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Hypnosis app aims to tame hot flashes for breast cancer patients
Symptom relief Recruiting nowPatients treated for breast cancer with hormone therapy (HT) suffer from hot flashes. This side effect impacts treatment adherence. Indeed, approximately 50% of women take less than 80% of the prescribed dose, and up to 50% abandon their treatment before the fifth year of prescri…
Phase: NA • Sponsor: Institut de Cancérologie de Lorraine • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC